MarginsXMarginsX
Home › Markets › Health Care › ILMN

Illumina Inc. (ILMN)

ILMN trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$198.00
-4.35% on the day
Market cap
$29.9B
Large cap
Revenue · 2025
$4.3B
-0.7% on 2024
Net income · 2025
$850.0M
19.6% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-28, https://www.sec.gov/Archives/edgar/data/1110803/000111080326000024/0001110803-26-000024-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-28.

Profile

FieldValue
TickerILMN on Nasdaq
SectorHealth Care
IndustryMedical Specialities
CountryUnited States
IPO year2000
SEC CIK0001110803
SEC industry codeLaboratory Analytical Instruments
Incorporated inDE

Financials · 2025

LineValue
Revenue$4.3B
Net income$850.0M
Operating income$807.0M
Net margin19.6%
Operating margin18.6%
Revenue growth-0.7%
Cash$1.4B
Total assets$6.6B
P/E (computed)35.2×
P/S (computed)6.9×

Warning signs

Cash runway
Cash-flow positive
$1.3B cash at September 27, 2026
Share count, 1 year
-1.0%
2025-10-24 to 2026-10-23 · -7.4% over 3 years
Going-concern doubt
No
10-Q filed October 30, 2026
Insider net buying, 12 months
-$592.8M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-10-30
Cash and burn$1.3B cash; operating cash flow $307.5M a quarter.Report 2026-09-27
Shares outstanding151,200,000 (2026-10-23); 152,800,000 a year earlier; 158,800,000 three years earlier. 3y figure adjusted for splits (1.028-for-1 overall).Cover page 2026-10-23
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, San Diego, California, United StatesPCAOB Form AP 2026-03-05
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $85K, sold $592.9M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-27
$1.1B$220.0M$419.0M$1.3B$0$4.5B10-Q 2026-10-30
Q2 2026
2026-06-28
$1.2B$207.0M$201.0M$1.0B$500.0M$4.5B10-Q 2026-07-31
Q1 2026
2026-03-29
$1.1B$134.0M$289.0M$1.1B$499.0M$4.4B10-Q 2026-05-04
Q4 2025
2025-12-28
$1.2B$334.0M$321.0M$1.4B$499.0M$4.3B10-K 2026-02-12
Q3 2025
2025-09-28
$1.1B$150.0M$284.0M$1.1B$998.0M$4.3B10-Q 2026-10-30
Q2 2025
2025-06-29
$1.1B$235.0M$234.0M$934.0M$499.0M$4.3B10-Q 2026-07-31
Q1 2025
2025-03-30
$1.0B$131.0M$240.0M$1.1B$499.0M$4.3B10-Q 2026-05-04
Q4 2024
2024-12-29
$1.1B$186.0M$364.0M$1.1B$499.0M$4.4B10-K 2026-02-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B22026-08-12
Latest annual report10-K2026-02-12
Latest quarterly / interim10-Q2026-10-30
Latest current report8-K2026-10-29
Latest proxyDEFA14A2026-04-09

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-2.9%
1 month-23.7%
3 months+7.5%
Year to date+57.8%
1 year+72.6%
From 52-week high-29.5%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical Specialities

TickerCompanyPriceDayMarket cap
LHLabcorp Holdings Inc.$372.46+0.53%$30.2B
DGXQuest Diagnostics Incorporated$262.21+1.01%$28.8B
CNCCentene Corporation$74.77+4.91%$37.0B
NTRANatera Inc.$288.48-9.59%$41.8B
GHGuardant Health Inc.$144.03-5.06%$19.5B
HUMHumana Inc.$461.25+2.50%$55.4B
MOHMolina Healthcare Inc$233.09+11.27%$12.2B
CIThe Cigna Group$300.16+1.06%$79.1B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier